Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 1
2012 4
2013 8
2014 11
2015 15
2016 9
2017 17
2018 17
2019 20
2020 19
2021 23
2022 23
2023 25
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Results by year

Filters applied: . Clear all
Page 1
Response of treatment-naive brain metastases to stereotactic radiosurgery.
Ene CI, Abi Faraj C, Beckham TH, Weinberg JS, Andersen CR, Haider AS, Rao G, Ferguson SD, Alvarez-Brenkenridge CA, Kim BYS, Heimberger AB, McCutcheon IE, Prabhu SS, Wang CM, Ghia AJ, McGovern SL, Chung C, McAleer MF, Tom MC, Perni S, Swanson TA, Yeboa DN, Briere TM, Huse JT, Fuller GN, Lang FF, Li J, Suki D, Sawaya RE. Ene CI, et al. Among authors: chung c. Nat Commun. 2024 May 2;15(1):3728. doi: 10.1038/s41467-024-47998-8. Nat Commun. 2024. PMID: 38697991
Additive Value of MR Simulation Prior to Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas.
Yadav D, Upadhyay R, Kumar VA, Chen MM, Johnson JM, Langshaw H, Curl BJ, Farhat M, Talpur W, Beckham TH, Yeboa DN, Swanson TA, Ghia AJ, Li J, Chung C. Yadav D, et al. Among authors: chung c. Pract Radiat Oncol. 2024 Apr 27:S1879-8500(24)00089-4. doi: 10.1016/j.prro.2024.04.009. Online ahead of print. Pract Radiat Oncol. 2024. PMID: 38685448
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights.
Sujit SJ, Aminu M, Karpinets TV, Chen P, Saad MB, Salehjahromi M, Boom JD, Qayati M, George JM, Allen H, Antonoff MB, Hong L, Hu X, Heeke S, Tran HT, Le X, Elamin YY, Altan M, Vokes NI, Sheshadri A, Lin J, Zhang J, Lu Y, Behrens C, Godoy MCB, Wu CC, Chang JY, Chung C, Jaffray DA, Wistuba II, Lee JJ, Vaporciyan AA, Gibbons DL, Heymach J, Zhang J, Cascone T, Wu J. Sujit SJ, et al. Among authors: chung c. Nat Commun. 2024 Apr 11;15(1):3152. doi: 10.1038/s41467-024-47512-0. Nat Commun. 2024. PMID: 38605064 Free PMC article.
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer.
Dogra P, Shinglot V, Ruiz-Ramírez J, Cave J, Butner JD, Schiavone C, Duda DG, Kaseb AO, Chung C, Koay EJ, Cristini V, Ozpolat B, Calin GA, Wang Z. Dogra P, et al. Among authors: chung c. medRxiv [Preprint]. 2024 Mar 15:2024.03.14.24304306. doi: 10.1101/2024.03.14.24304306. medRxiv. 2024. PMID: 38559070 Free PMC article. Preprint.
Clinical Benefit from Docetaxel +/- Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy.
Qin K, Wang K, Li S, Hong L, Padmakumar P, Waree R, Hubert SM, Le X, Vokes N, Rai K, Vaporciyan A, Gibbons DL, Heymach JV, Lee JJ, Woodman SE, Chung C, Jaffray DA, Altan M, Lou Y, Zhang J. Qin K, et al. Among authors: chung c. Cancers (Basel). 2024 Feb 26;16(5):935. doi: 10.3390/cancers16050935. Cancers (Basel). 2024. PMID: 38473297 Free PMC article.
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept.
Salehjahromi M, Karpinets TV, Sujit SJ, Qayati M, Chen P, Aminu M, Saad MB, Bandyopadhyay R, Hong L, Sheshadri A, Lin J, Antonoff MB, Sepesi B, Ostrin EJ, Toumazis I, Huang P, Cheng C, Cascone T, Vokes NI, Behrens C, Siewerdsen JH, Hazle JD, Chang JY, Zhang J, Lu Y, Godoy MCB, Chung C, Jaffray D, Wistuba I, Lee JJ, Vaporciyan AA, Gibbons DL, Gladish G, Heymach JV, Wu CC, Zhang J, Wu J. Salehjahromi M, et al. Among authors: chung c. Cell Rep Med. 2024 Mar 19;5(3):101463. doi: 10.1016/j.xcrm.2024.101463. Epub 2024 Mar 11. Cell Rep Med. 2024. PMID: 38471502 Free PMC article.
Expert-centered Evaluation of Deep Learning Algorithms for Brain Tumor Segmentation.
Hoebel KV, Bridge CP, Ahmed S, Akintola O, Chung C, Huang RY, Johnson JM, Kim A, Ly KI, Chang K, Patel J, Pinho M, Batchelor TT, Rosen BR, Gerstner ER, Kalpathy-Cramer J. Hoebel KV, et al. Among authors: chung c. Radiol Artif Intell. 2024 Jan;6(1):e220231. doi: 10.1148/ryai.220231. Radiol Artif Intell. 2024. PMID: 38197800 Free PMC article. Clinical Trial.
Designing clinical trials for patients who are not average.
Yankeelov TE, Hormuth DA 2nd, Lima EABF, Lorenzo G, Wu C, Okereke LC, Rauch GM, Venkatesan AM, Chung C. Yankeelov TE, et al. Among authors: chung c. iScience. 2023 Nov 29;27(1):108589. doi: 10.1016/j.isci.2023.108589. eCollection 2024 Jan 19. iScience. 2023. PMID: 38169893 Free PMC article. Review.
181 results